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The zinc-finger transcription factor Krϋppel-like factor 2 (KLF2) transduces blood flow into
molecular signals responsible for a wide range of responses within the vasculature. KLF2
maintains a healthy, quiescent endothelial phenotype. Previous studies report a range of
phenotypes following morpholino antisense oligonucleotide-induced klf2a knockdown in
zebrafish. Targeted genome editing is an increasingly applied method for functional assess-
ment of candidate genes. We therefore generated a stable klf2amutant zebrafish and char-
acterised its cardiovascular and haematopoietic development.
Methods and Results
Using Transcription Activator-Like Effector Nucleases (TALEN) we generated a klf2a
mutant (klf2ash317) with a 14bp deletion leading to a premature stop codon in exon 2. West-
ern blotting confirmed loss of wild type Klf2a protein and the presence of a truncated protein
in klf2ash317 mutants. Homozygous klf2ash317 mutants exhibit no defects in vascular pattern-
ing, survive to adulthood and are fertile, without displaying previously described morphant
phenotypes such as high-output cardiac failure, reduced haematopoetic stem cell (HSC)
development or impaired formation of the 5th accessory aortic arch. Homozygous klf2ash317
mutation did not reduce angiogenesis in zebrafish with homozygous mutations in von Hip-
pel Lindau (vhl), a form of angiogenesis that is dependent on blood flow. We examined
expression of three klf family members in wildtype and klf2ash317 zebrafish. We detected
vascular expression of klf2b (but not klf4a or biklf/klf4b/klf17) in wildtypes but found no dif-
ferences in expression that might account for the lack of phenotype in klf2ash317 mutants.
klf2bmorpholino knockdown did not affect heart rate or impair formation of the 5th acces-
sory aortic arch in either wildtypes or klf2ash317 mutants.
PLOS ONE | DOI:10.1371/journal.pone.0141611 October 27, 2015 1 / 22
OPEN ACCESS
Citation: Novodvorsky P, Watson O, Gray C,
Wilkinson RN, Reeve S, Smythe C, et al. (2015)
klf2ash317 Mutant Zebrafish Do Not Recapitulate
Morpholino-Induced Vascular and Haematopoietic
Phenotypes. PLoS ONE 10(10): e0141611.
doi:10.1371/journal.pone.0141611
Editor: Ramani Ramchandran, Medical College of
Wisconsin, UNITED STATES
Received: May 2, 2015
Accepted: October 9, 2015
Published: October 27, 2015
Copyright: © 2015 Novodvorsky et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: Medical Research Council (www.mrc.ac.
uk) Centre Grant (G0700091) provided a clinical
training fellowship to PN. This work was supported by
British Heart Foundation (www.bhf.org.uk) project
grants 09/287/28051 and 12/12/29433 awarded to
TJAC. FvE was supported by European Commission
(http://cordis.europa.eu/result/rcn/140792_en.html) as
part of its Seventh Framework Programme (EC Grant
Agreement HEALTH-F4-2010-242048). The funders
had no role in study design, data collection and
Conclusions
The klf2ash317 mutation produces a truncated Klf2a protein but, unlike morpholino induced
klf2a knockdown, does not affect cardiovascular development.
Introduction
KLF2 belongs to the KLF zinc finger transcription factor family, characterised by three tandem
C2H2 zinc fingers that serve as a DNA binding motif [1]. Since its characterisation in mice [1]
and humans [2] it is clear that mammalian KLF2 plays important roles in vascular develop-
ment and homeostasis [3]. KLF2 modulates expression of genes critical in regulating vascular
tone [4, 5], thrombosis [6], inflammation [3, 4] barrier function [7] and antioxidative proper-
ties of endothelium [8]. Within the vascular wall, KLF2 is expressed exclusively in endothelium
[3, 5, 9]. Endothelial KLF2 expression is induced by blood flow via mechanotransduction [3,
10], as well as via non flow-dependent mechanisms such as inflammatory cytokines or statins
[4, 6, 11]. Homozygous Klf2 knockout mice die between E12.5–14.5 from intra-embryonic and
intra-amniotic haemorrhaging associated with defective blood vessel morphology. Impaired
vascular smooth muscle cell and pericyte migration resulting in failure to organize into a com-
pact tunica media has been reported [12, 13], although while another group confirmed the
stage of lethality (E11.5–13.5) and abdominal bleeding, they but did not detect vessel wall
abnormalities [14]. Conditional Klf2 deletion in murine embryonic tissues confirms that endo-
thelial Klf2 deletion is responsible for embryonic mortality [15].
The zebrafish (Danio rerio) is an increasingly popular model to study vascular development
[16]. Zebrafish possess two KLF2 paralogs, klf2a and klf2b [17] and klf2a expression in embry-
onic zebrafish vasculature is (like mammalian KLF2) regulated by blood flow [3].
Assessment of gene function in zebrafish has often used morpholino antisense oligonucleo-
tide-mediated gene knockdown, and several studies have reported the effect of klf2a knock-
down on zebrafish cardiovascular and haematopoietic development. klf2a knockdown has
been reported to cause high-output cardiac failure with pericardial oedema and high aortic
blood flow velocity attributed to loss of smooth muscle tone [15]. klf2a knockdown induced
failure to form the 5th accessory aortic arch (AA5x) although with otherwise preserved vascular
patterning [18]. In relation to haematopoietic development klf2a knockdown impaired mainte-
nance of haematopoietic stem cell (HSC) gene expression via a blood flow dependent signalling
cascade involving nitric oxide (NO) [19].
Morpholino oligonucleotides (MO) remain commonly used in zebrafish reverse genetic
studies. However, their reliability has been called into question [20]. The advantages of MOs in
terms of cost and speed are counterbalanced by their temporary and incomplete action and
potential for off-target effects and toxicity [21]. The development of targeted genome editing to
create stable, heritable mutations in genes of interest avoids the disadvantages of morpholino
use. Several techniques are available, including Zinc Finger Nucleases (ZFN) [22], Transcrip-
tion Activator-like Effector Nucleases (TALEN) [23] and most recently Clustered Regularly
Interspaced Short Palindromic Repeats/CRISPR-associated systems (CRISPR/Cas9) [24].
These induce site-specific double stranded DNA breaks that are repaired by error-prone non-
homologous end joining DNA repair resulting in mutations that can disrupt the reading frame.
Targeted mutation has been proposed to be a more reliable way of assessing gene function
[20]. Recent publications have shown that several published morphants phenotypes are not
reproduced in mutants [25]. Very recently, Rossi et al. found that the severe vascular defect
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induced by egfl7morpholino knockdown was not seen in egfl7mutants, due to a compensatory
upregulation of Emilin 2 and 3 not seen in morphants [26].
The existence of mechanisms that compensate for the effects of loss-of-function mutations
would explain the low rate of overt phenotypes seen in the Sanger zebrafish mutagenesis proj-
ect [27]. However, as zebrafish were first established as a model for forward mutagenesis
screens [28–30], clearly not all mutations can be so “rescued”. There is therefore a pressing
need to rapidly establish which mutations can be compensated for, and which cannot.
We used TALENs to generate a stable klf2amutant line (named klf2ash317). This mutation
produces an aberrant mRNA transcript that is predicted to produce a significantly truncated
klf2a protein without the essential DNA binding motifs. However, homozygous klf2ash317
mutants exhibit no phenotypic differences compared to wildtypes (WT) and did not reproduce
previously described klf2amorphant phenotypes, nor did they show any effect in miR-126 lev-
els. We examined the expression patterns of three evolutionary closest klf family members;
klf2b, klf4a and biklf/klf4b/klf17 in the search for a gene that might compensate for the muta-
tion in klf2a. Although we detected klf2b expression in the vasculature, which has not been
described previously, we found no differences in expression of these genes between klf2ash317




Zebrafish were raised in the Bateson Centre aquaria and fed Artemia nauplii. Zebrafish were
kept on a constant 14 hour on /10 hour off light cycle at 28°C. Studies performed on zebrafish
conformed to Directive 2010/63/EU of the European Parliament and Home Office regulations
under Home Office project licences 40/3434 held by TJAC and 40/3082 held by FVE.
Fish Strains
hey2/gridlockmutants [31] were kindly supplied by Randall Peterson. vhlhu2117 [32] was
obtained from Hubrecht Institute in Utrecht, Netherlands and was crossed with Tg(fli1:eGFP)
[33] kindly supplied by Brant Weinstein. Tg(kdrl:HRAS-mCherry) [34] was kindly supplied by
Arndt Siekmann and Tg(flk1:EGFP-nls) was kindly supplied by Markus Affolter. klf2ash317
mutant line was generated in Nacre wild type (WT) strain and was crossed with Tg(kdrl:HRAS-
mCherry;flk1:EGFP-nls) and with vhlhu2117 +/−;Tg(fli1:eGFP).
Morpholino Studies
Morpholino oligonucleotides (GENE-TOOLS, OR, USA) were diluted with ultra-pure (miliQ)
water and phenol red (SIGMA) and 2ng of each were injected into one-cell stage embryos.
Morpholino sequences: tnnt2morpholino 50 CATGTTTGCTCTGACTTGACACGCA 30 as
published [35], klf2bmorpholino 50 AGTGTCAAATACTTACATCCTCCCA 30, control mor-
pholino 50 CCTCTTACCTCAGTTACAATTTATA 30 (GENE TOOLS stock control).
Drug Treatments
In order to reversibly block cardiac contraction and stop blood flow embryos were treated with
the anaesthetic tricaine [2.53mM] or the myosin ATPase inhibitor 2,3-butanedione 2-mono-
xime (BDM) [15mM] (both SIGMA) from 46hpf until 65hpf as previously published [18, 36].
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RNA Extraction, Reverse Transcription and Polymerase Chain
Reaction
Total RNA was extracted from pools of 30 embryos or unfertilised eggs using TRIzol (LIFE
TECHNOLOGIES) according to manufacturer`s instructions. Total RNA was reversely
transcribed into complementary DNA using the VERSO cDNA Synthesis Kit (THERMO
SCIENTIFIC). Primers for amplification of klf2a, klf2b, and gapdh were: klf2a F 5`GGATC
CATGGCTTTGAGTGGAACG 3`, klf2a R 5`GAATTCCTACATATGACGTTTCAT 3`, klf2b
F 5'-GCCTTCGATTTCAACGTTTGC-3', klf2b R 5'-ATCCTCGTCATCCTTACGGC-3',
gapdh F 5`AGGCTTCTCACAAACGAGGA, gapdh R 5`GCCATCAGGTCACATACACG 3`.
Quantitative PCR (qPCR) of zebrafish mature miR-126-5p was performed according to the
manufacturer’s instructions using the TaqMan MicroRNA Assay. Total RNA from 72hpf zeb-
rafish embryos was purified using Trizol. cDNA was prepared using the TaqMan microRNA
Reverse Transcription kit (4366596, APPLIED BIOSYSTEMS) and qPCR performed using
miR-126-5p and U6 TaqMan Assays (4427975 and 4427975, APPLIED BIOSYSTEMS). The
primers used for reverse transcription and qPCR were supplied with each assay. The qPCR
primer is a stem-loop oligonucleotide containing the sequence of the mature miR-126-5p
(CAUUAUUACUUUUGGUACGCG). qPCR was performed in duplicate using an ABI
7900HT Fast Real-Time PCR System. Expression of miR-126-5p was normalized to U6 for rel-
ative quantification. Individual points represent relative quantification of miR-126-5p in a pool
of embryos relative to mean expression in the wild-type group. Summary data is displayed as
mean ± standard error of the mean (SEM). Statistical comparison was made using a two-tailed
Student’s t-test on log-transformed data.
Measurement of Cardiovascular Performance
Heart Rate. Embryos were kept in individual dishes and individually removed from the
28°C incubator immediately prior to measurement to minimize the effect of environmental
temperature on heart rate [37]. Heart rates were measured directly by eye under a stereomicro-
scope for 30 seconds.
Blood flow velocity. Particle image velocimetry (PIV) analysis using erythrocytes as tracer
particles was used to measure aortic blood velocity in the mid aorta immediately above the clo-
aca. Zebrafish embryos were imaged at 10x magnification and at 300 frames/second using a
high speed camera (OLYMPUS IX81) and Video Savant 4.0 digital video recording software
(IO INDUSTRIES). 400 images (frames) in.tiff format per each embryo were recorded. Images
were analysed using ImageJ (version 1.45s public domain software http://imagej.nih.gov/ij) to
obtain a kymograph with lines representing movements of individual erythrocytes in real time.
Kymographs were uploaded to custom made software CORRELATOR which calculated
instantaneous erythrocyte velocities throughout the cardiac cycle. Knowing the ratios of pixel/
μm (0.8pixel/μm), pixel/frame (1:1) and the rate of imaging (300frames/second), velocity (v)
was calculated as follows: v = distance/time [μm/sec]. Average erythrocyte velocity per cardiac
cycle was calculated by averaging all instantaneous velocities measured during the cardiac
cycle. Additionally, cardiac cycles from all embryos of the same group were put in phase, and
average instantaneous erythrocyte velocities for each frame were calculated and plotted as a
single velocity curve.
Whole-Mount In Situ Hybridization (WISH)
WISH was performed according to previously published protocols [38, 39]. Embryos were
permeabilized with proteinase K (ROCHE) [15μg/ml] for following times depending on the
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developmental stage: 0min (24hpf), 15min (36hpf), 40min (48hpf), 80min (72hpf), 100min
(4dpf) and 150min (5dpf). Maleic acid buffer was used instead of phosphate buffered saline for
day 2 and day 3 washes. Expression was detected with digoxigenin (ROCHE) labelled ribop-
robes and resolved using BM Purple (ROCHE). EST clone IMAGp998A0510285Q (IMA-
GENES) containing full-length klf2a cDNA sequence was digested with XBaI and EcoRI (both
NEB) resulting in a 1144bp fragment which was inserted into Bluescript KS expression plasmid
and subsequently used for klf2a antisense riboprobe synthesis (EcoRI (NEB) and T7 RNA poly-
merase (ROCHE)). Total embryonic RNA at 48hpf was used as a template for klf2b, klf4a and
biklf/klf4b/klf17 riboprobes synthesis. The following primers were designed to amplify approx.
1000bp cDNA fragments: klf2b F 5`CGTGGACATGGCTTTACCTT 3`, klf2b R 5`ATGGGAG
CTTTTGGTGTACG 3`, klf4a F 5`TTGATAGCATGGCACTGAGC 3`, klf4a R 5`CCTGC
GGAAATCCAGAATAA 3`, biklf/klf4b/klf17 F 5`ACCCCGGACATGAATTATCA 3`, biklf/
klf4b/klf17 R 5`TGTCCGGTGTGTTTCCTGTA 3`. T3 promoter sequence 5`CATTAACCCT
CACTAAAGGGAA 3`was added to 5`end of each of the F primers and T7 promoter sequence
5`TAATACGACTCACTATAGGG 3`was added to 5`end of each of the R primers. RT-PCR
and subsequent PCR amplification of corresponding cDNA was performed in a single step
using Superscript III One-Step RT-PCR kit (INVITROGEN) following the manufacturer`s
instructions. Antisense riboprobes were synthesized using T7 RNA polymerase (ROCHE). The
remaining riboprobes used in this study have been kindly donated by other research groups:
dll4 [40] runx1 [41] and cmyb [42].
Microscopy
Visual assessment of embryos, monitoring of WISH staining and heart rate counting were per-
formed using a Leica S6E stereo microscope (LEICA MICROSYSTEMS). Images of live
embryos andWISH images were taken using a Leica M165 FC fluorescent stereo microscope
with Leica DFC310 FX camera (both by LEICAMICROSYSTEMS). Fluorescence microscopy
was performed using UltraVIEW Vox spinning disc confocal microscope and Volocity v5.3.2
imaging software (both by PERKIN ELMER). Zebrafish embryos were anaesthetised with Tri-
caine and mounted on a cover slip in 1% low-melting point agarose prior to imaging. Images
were taken in 2μm slices across the region of interest and digitally processed by focal plane
merging (Z stacking). Merged images were further analysed using ImageJ.
Western Blotting
Total protein was extracted from genotyped zebrafish embryos at 5dpf (4 embryos per group)
using RIPA lysis buffer (SIGMA-ALDRICH) with added Halt Protease and Phosphatase inhib-
itor cocktail (THERMO SCIENTIFIC). Embryos were homogenised using an Eppendorf pestle
(SIGMA-ALDRICH) and left on ice for 30min. Lysate was centrifuged at 14000rpm for 10min
at 4°C and the supernatant was separated and protein amounts quantified using a Bradford
assay. Protein samples were then mixed with 1M dithiothreitol (DTT) (SIGMA-ALDRICH)
and NuPAGE LDS Sample Buffer (LIFE TECHNOLOGIES) heated to 95°C for 5min and
loaded onto a NuPAGE NOVEX 4–12% Bis-Tris gel (LIFE TECHNOLOGIES). After the elec-
trophoretic separation, proteins were transferred to Immobilon-P PVDF transfer membranes
(MILLIPORE) using the Xcell II Blot Module (LIFE TECHNOLOGIES). After blocking with
5% non-fat milk for 1 hour at RT, transfer membranes were incubated with rabbit anti-mouse
polyclonal Klf2 antibody (raised against a polypeptide containing AAs 70–270 of mouse wild-
type Klf2a protein) (1:500) (MILLIPORE, Cat.# 09–820) or with a rabbit anti-human β-actin
antibody (1:10000) (CELL SIGNALLING, Cat.# 4967) overnight. Membranes were washed in
TBSTw (Tris buffered saline plus Tween 20: 136.8mMNaCl, 24.8mM Tris, 0.1% Tween 20
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(vol/vol) (all from SIGMA), pH 7.6) for 3x5min on a rocker and incubated with a secondary
antibody (goat anti-rabbit polyclonal antibody with conjugated horseradish peroxidase (HRP),
1:1000) (DAKO) for 45min on a rocker. After thorough washing of the membranes, immobi-
lised proteins were detected by the EZ-ECL Chemiluminiscence Detection Kit (BIOLOGICAL
INDUSTRIES).
klf2a TALENMutagenesis
We followed a published protocol for targeted TALEN mutagenesis [23]. klf2a genomic
sequence was submitted to the Old TALEN Targeter software at https://tale-nt.cac.cornell.edu/
node/add/talen-old. A target site at the 5`end of exon 2 5`TCAACCCATCACCACCTCCA
CCG/AT[ACACCACCAGCCTACTGGC]AGAGCTTCTGCAGTCTG 3`(19bp spacer
sequence between target sequences for L and R TALEN subunits is annotated with square
brackets) containing the XcmI (NEB) restriction enzyme site 5`CCANNNNNNNNNTGG
3`was chosen for the mutagenesis. Primers flanking the target site were designed amplifying a
281bp PCR product; klf2a TAL XcmI F 5`CAGGCGACTACAGAATGCAA 3`and klf2a TAL
XcmI R 5`GCCCTCTTGTTTGACTTTGG 3`. Genomic DNA extraction was performed using
REDExtract-N-Amp™ Tissue PCR Kit (SIGMA-ALDRICH). XcmI (NEB) restriction enzyme
digest (3 hours, 37°C) results in generation of 180bp and 101bp fragments. Successful muta-
genesis is indicated by the loss of the restriction site and the presence of an undigested 281bp
band after the XcmI (NEB) digest. Following the assembly and capped mRNA synthesis, 1.5ng
of capped mRNA coding for the klf2a TALEN construct was injected per embryo at one cell
stage.
Statistical Analysis
F1 klf2amutant studies were blinded to whether embryos were homozygous mutants, hetero-
zygotes or wildtype (after imaging and quantification embryos were euthanized and geno-
typed). Statistical analysis was carried out using GraphPad Prism v5.04 software. Quantitative
data are presented as mean ± standard error of the mean (SEM). Statistical comparisons
between two groups were made by Student’s t-test. Statistical significance is indicated as:
ns = non-significant,  = p<0.05,  = p<0.01,  = p<0.001,  = p<0.0001.
Results
The Expression of klf2a in Developing Zebrafish Embryos
We analysed klf2a expression during zebrafish embryonic development daily from 1 to 5 days
post fertilisation (dpf) in wildtype embryos using WISH (Fig 1A). Prior to onset of blood flow
(24-26hpf) we could detect only non-vascular klf2a expression notably in the cloaca (Fig 1A,
grey arrowheads) and in cells abutting the most posterior notochord (Fig 1A, black arrows).
After onset of blood flow, klf2a was expressed in the developing vasculature, in particular at
48hpf (Fig 1A, red arrow). Cross sections at 48hpf confirmed vascular expression of klf2a (Fig
1B).These observations confirm previously published data on klf2a expression in early embry-
onic stages [17]. We next extended our studies to later stages of development to 5dpf and
found klf2a expression in the trunk vasculature, intersegmental vessels and cardiac outflow
tract (Fig 1A, red arrows and black arrowheads respectively). klf2amRNA in the cardiac out-
flow tract was detectable up to 5dpf, whereas klf2a expression in the trunk vasculature and
intersegmental vessels was only detectable up to 72hpf (Fig 1A). From 72hpf onwards, klf2a
was expressed in the subintestinal veins that subsequently form the hepatic vein at 5dpf
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Fig 1. klf2a expression patterns in developing zebrafish embryos. (A) klf2a expression patterns were examined using whole-mount in situ hybridisation.
Grey arrowheads indicate cloaca, black arrows indicate cells lateral to the most posterior notochord, white arrows indicate pectoral fin, red arrows indicate
trunk vasculature, black arrowheads indicate the cardiac outflow tract, white arrowheads indicate neuromasts and green arrows indicate subintestinal veins
(3dpf) or hepatic portal vein (5dpf). Numbers in the top left corners indicate number of embryos with similar staining patterns out of total number of embryos
examined. Scale bar = 500μm. (B) Cross sections of a 48hpf wildtype embryo showing klf2a expression in dorsal aorta (red arrow), parachordal vessel (black
arrow), intersegmental vessel (ISV) (black arrowhead) and dorsal longitudinal anastomotic vessel (DLAV) (dotted black arrow). Anatomical positions of
sections are indicated by the red lines and numbers on the top panel figure with corresponding cross sections images in the bottom panel. Scale bar = 500μm
(top panel) and 100μm (bottom panel).
doi:10.1371/journal.pone.0141611.g001
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(Fig 1A, green arrows). We also detected klf2a expression in the neuromasts of the lateral line
from 72hpf onwards (Fig 1A, white arrowheads).
We confirmed that klf2a expression in the zebrafish vasculature is dependent on blood flow
using three distinct approaches. These were by preventing cardiac contraction by morpholino
antisense knockdown of cardiac troponin T2; preventing aortic blood flow to the trunk due to
the aortic occlusion caused by homozygous mutation in hey2/gridlock; and finally by chemi-
cally-induced cessation of established blood flow between 46-65hpf by incubation in tricaine.
When we examined vascular klf2a expression, this was reduced in all three models of hindered
flow, in keeping with previous studies using tnnt2 knockdown [3] (S1 Fig).
Generation of a Stable klf2aMutant Line
To examine the role of klf2a on cardiovascular and haematopoietic development we generated
a klf2amutant zebrafish using TALEN. The site for mutagenesis was chosen at the 5`end of
exon 2 (Fig 2A). Mutations that produce a premature stop codon in this region are predicted to
result in translation of a truncated Klf2a protein lacking the 3 tandem zinc fingers DNA bind-
ing motif located at the C terminus of the wildtype Klf2a protein (Fig 2B), rendering it unlikely
to function as a transcription factor. We raised TALEN injected embryos and sequenced their
genomic DNA and identified a founder carrying an allele with a 14 base pair (bp) deletion that
disrupted the reading frame at the target site and generated a premature stop codon 14bp
downstream. This allele was named klf2ash317 and is predicted to generate a truncated Klf2a
protein with molecular weight of 13.15 kilodalton (kDa) (Fig 2B). All mutant fish from the F1,
F2 and F3 generation used in subsequent experiments were genotyped and the klf2ash317 muta-
tion confirmed by sequencing.
To determine the effect of the klf2ash317 mutation on the mRNA transcript, we extracted
whole embryonic RNA from 30 pooled embryos from the F3 generation of klf2ash317 mutants.
klf2a coding sequence was reversely transcribed, PCR amplified, cloned into an expression
plasmid and transformed into bacterial cells. 23 separate colonies were sequenced. All con-
firmed the expected klf2ash317 sequence without any additional transcripts (S2 Fig). We did not
therefore find any evidence that the klf2ash317 mutation induces alternative splicing.
Targeted mutation can induce gene loss-of-function by a number of mechanisms. As well as
production of a truncated or non-functional protein, the mRNA can be targeted for nonsense
mediated decay (NMD) [43]. We examined wither the klf2ash317 mutation induced NMD by
performing in situ hybridisation for klf2a in wildtypes and homozygous klf2ash317 mutants, but
found no difference in mRNA expression (S3 Fig). This, together with the fact that we could
amplify and clone the expected mRNA transcript by rt-PCR (S2 Fig) strongly suggests that the
klf2ash317 mutation does not induce nonsense-mediated decay.
We next attempted to examine the effect of the klf2ash317 mutation on Klf2a protein expres-
sion and size by western blotting in wildtype and klf2ash317 mutant embryos (Fig 2C). Although
there are no monoclonal antibodies available against zebrafish Klf2a we were able to obtain
and use an anti-mouse polyclonal Klf2a antibody previously shown to bind to zebrafish Klf2a
[19]. As might be expected from a polyclonal antibody raised against a largely conserved region
of several Klf genes this blot shows multiple bands consistent with the presence of Klf2a, in
addition to other bands which are consistent with Klf4a and Biklf/Klf4b/Klf17 expression
(predicted molecular weights 38kDa and 47kDa respectively; indicated by asterixes in Fig 2C).
However, a band likely to represent wildtype Klf2a protein with the correct size of 43kDa was
detected in either wildtype or heterozygous klf2ash317 embryos (Fig 2C). This band was greatly
reduced in homozygous klf2ash31 mutants, with the residual band migrating with a similar
molecular weight likely to reflect the expression of Klf2b (predicted molecular weight
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41.2kDa). Additionally, two bands of approximately 31-33kDa were detected in klf2ash317
homozygous mutants, probably representing truncated Klf2a protein (Fig 2C). Although larger
that the predicted molecular mass of Klf2a sh317 protein, the truncated protein would be
expected to be very acidic (ph ~4, versus ~7.8 for full-length protein) and contain a significant
proportion of proline residues, both features that contribute to aberrant behaviour on
SDS-PAGE.
To determine the presence and potential contribution of maternal klf2amRNA we analysed
klf2a expression by RT-PCR in unfertilised zebrafish embryos. We found no evidence of mater-
nal klf2amRNA in unfertilised zebrafish eggs (Fig 2D).
Fig 2. Generation of a stable klf2ash317 mutant line. (A) Schematic structure of wildtype klf2a gene with genomic sequence at the TALENmutagenesis
site. XcmI restriction site is indicated by the green line and the 19bp spacer for the TALEN structure of choice is indicated by the black line. The 14bp deletion
identified in the klf2ash317 allele is indicated by the sequence in red. (B) Schematic structure of Klf2a wildtype and Klf2a sh317 mutant proteins with amino
acid (AA) lengths and predicted molecular weights in kilodaltons (kDa) Klf2a transactivation domain is in purple and transrepression domain is in yellow
colour. (C) Substantial reduction of the 43kDa band representing the full-length Klf2a protein can be seen in a western blot of whole-embryo protein samples
extracted from the F3 generation of klf2ash317 mutant embryos at 5dpf, compared to wildtype embryos and heterozygous klf2ash317 carriers. Additionally, two
bands running at approximately 33kDa can be seen in the klf2ash317 mutant, possibly representing truncated Klf2a. Asterixes indicate bands of approx.
molecular weights of 38kDa and 47kDa consistent with expression of Klf4a and Biklf/Klf4b/Klf17 respectively, present in all three lanes in equal intensity. β
actin was used as a loading control. (D) klf2a coding sequence was amplified from the control cDNA originating from 48hpf wildtype embryos giving an
expected 1155bp PCR product. No band was detected in the sample with cDNA from unfertilised embryos (unf. cDNA) indicating the absence of maternal
klf2amRNA in unfertilised embryos. No 1674bp band was detected in unfertilised cDNA or control cDNA confirming absence of genomic DNA contamination.
gapdhwas used as a positive control. A band of expected size was detected in both the unfertilised eggs cDNA and control cDNA lanes indicating maternal
gapdhmRNA in unfertilised zebrafish eggs. Abbreviations: -E: negative control with no reverse transcriptase added during reverse transcription (RT). -RNA:
negative control with no RNA added during RT. B: blank, no template added to the PCR reaction. Abbreviations: L: Hyperladder II (NEB).
doi:10.1371/journal.pone.0141611.g002
klf2aMutant Zebrafish Display No Cardiovascular Phenotype
PLOS ONE | DOI:10.1371/journal.pone.0141611 October 27, 2015 9 / 22
Taken together, these data strongly suggest that the klf2ash317 mutation induces a significant
truncation of the klf2a protein that is highly likely to perturb its function as a transcription
factor.
Characterisation of the klf2ash317 Mutant Line
Homozygous klf2ash317 mutants displayed no morphological abnormalities compared to wild-
types by at least 5dpf (Fig 3). In contrast to previously described klf2amorphants [15], no peri-
cardial oedema was observed at any stage. klf2ash317 mutants showed no difference in heart
rate or blood flow velocity in the dorsal aorta at 48hpf compared to wildtypes, in contrast to
the high-output cardiac failure described in klf2amorphants [15] (Fig 4). Furthermore, we
raised homozygous klf2ash317 mutants to adulthood and both these (F2 generation) and
incrossed offspring (F3) were viable and fertile, making late-onset cardiac failure or major car-
diovascular defects unlikely and excluding maternal effects that compensate for the mutation
when homozygous mutants are derived from heterozygous females.
Next we examined the vascular anatomy of klf2ash317 mutant embryos. We crossed
klf2ash317 mutants with the double transgenic line Tg(kdrl:HRAS-mCherry;flk1:EGFP-nls) that
differentially labels endothelial cell cytoplasm and nuclei. We found no differences in vascular
patterning in klf2ash317 mutants (Fig 5A). Specifically, we examined the trunk vasculature and
found no abnormal formation of the axial or intersegmental vessels, nor any difference in
endothelial cell number in these regions (Fig 5B and 5C).Formation of the 5th accessory aortic
arch (AA5x) has been shown to be impaired either in klf2amorphants or in the absence of
blood flow [18]. We confirmed that in our hands, formation of the AA5x is blood flow depen-
dent (S4 Fig) but formation of the AA5x was unaffected in klf2ash317 mutants (Fig 5A).
We recently showed that the excessive hypoxic signalling-driven trunk vessel angiogenesis
in homozygous vhlmutants (vhlhu2117) is blood flow dependent [44]. Since klf2a is a major
endothelial flow responsive transcription factor, we determined the effect of the klf2ash317
mutation on angiogenesis in vhlhu2117 mutants. Heterozygotes for klf2ash317 and vhlhu2117 in
the Tg(fli1:eGFP) background were incrossed. Embryos homozygous for both klf2ash317 and
vhlhu2117 still display aberrant intersegmental vessel development (Fig 6) indicating that the
klf2ash317 mutation does not alter this process.
Since maintenance of haematopoetic stem cell (HSC) gene expression is impaired in klf2a
morphants, or in the absence of blood flow [19] we examined this in klf2ash317 mutants. While
we confirmed that runx1 and cmyb expression was reduced in the absence of blood flow (S5
Fig), expression of both genes was unaffected in homozygous klf2ash317 mutants (Fig 7).
Since homozygous klf2ash317 mutants (unlike klf2amorphants) displayed no cardiovascular
phenotype, we sought to determine whether this could be explained by redundancy between
other klf family members. We examined expression of the three genes phylogenetically closest
to klf2a, namely the paralog klf2b and both KLF4 orthologs klf4a and biklf/klf4b/klf17, to assess
whether these might be compensating for the klf2ash317 mutation. In addition to the close
molecular phylogeny to KLF2, KLF4 has been identified as another endothelial blood flow
dependent transcription factor in human and mouse [45, 46]. Vascular expression of klf2b,
klf4a or biklf/klf4b/klf17 in wildtype zebrafish embryos has not been described [17, 47].
At 48hpf klf2bmRNA was detected in the cleithrum and the mesenchyme of the pectoral
fin bud (Fig 8, black arrow) and in the epidermal cells (Fig 8, red arrowhead) in keeping with
previously published data [17, 48]. Additionally, klf2bmRNA was detected in the ISVs of some
wildtype and klf2ash317 mutant embryos (Fig 8, red arrows). At 72hpf klf2b expression persisted
in the pectoral fin and epidermis. As in 48hpf embryos, a small proportion of both wildtype
and klf2ash317 mutants at 72hpf exhibited vascular expression of klf2b in the ISVs and the
klf2aMutant Zebrafish Display No Cardiovascular Phenotype
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Fig 3. Comparison of the morphology of wildtype and klf2ash317 mutant embryos. There are no obvious morphological differences between wildtype
and klf2ash317 mutant embryos up to 5dpf and also beyond up to adulthood (not shown). Scale bar = 500μm.
doi:10.1371/journal.pone.0141611.g003
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subintestinal veins (Fig 8, red arrows). No differences in klf2b expression were apparent
between wildtype and klf2ash317 mutants.
We detected klf4a expression in the epidermis (Fig 9, black arrows) and in the pectoral fin
(Fig 9, red arrowheads) of 48hpf wildtype embryos in keeping with previously published data
[47]. klf4a expression in klf2ash317 mutants was not different to wildtype and no vascular
expression of klf4a was detected (Fig 9). Similarly, in situ hybridisation for biklf/klf4b/klf17 at
48hpf confirmed previously published data [17] showing expression in the neuromasts of the
lateral line organ (Fig 9, black arrowheads) and in the hatching gland (Fig 9, red arrows).
Again, no differences in biklf/klf4b/klf17 expression were observed between wildytpe and
klf2ash317 mutants and no vascular biklf/klf4b/klf17 expression was detected (Fig 9).
The above detailed experiments found no evidence of compensatory upregulation of klf2b,
klf4a, or biklf/klf4b/klf17 in klf2ash317 mutants. However, even without evidence of upregula-
tion, normal levels of expression of these genes could conceivable compensate for loss-of-func-
tion of klf2a. Since only klf2b was seen to be expressed in the vasculature, we examined
whether morpholino knockdown of klf2b induced cardiovascular phenotypes in klf2ash317
mutants. Morpholino-induced klf2b knockdown had no effect on either heart rate or AA5x for-
mation in either heterozygous or homozygous klf2ash317 mutants, strongly suggesting that
redundancy between klf2a and klf2b does not explain the lack of a cardiovascular phenotype in
klf2ash317 mutants (Fig 10).
Fig 4. Comparison of heart rates and blood flow velocities of wildtype and klf2ash317 mutant embryos
at 48hpf (A) No significant differences in heart rates were observed. (B) Instantaneous blood flow
velocities throughout a single cardiac cycle in wildtype and klf2ash317 mutants. (C) Average
instantaneous blood flow velocities per cardiac cycle (n = 24, unpaired t-test).
doi:10.1371/journal.pone.0141611.g004
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Fig 5. The vascular anatomy of homozygous klf2ash317 mutants. (A) Formation of the 5th accessory
aortic arch (AA5x) connecting the 5th and 6th aortic arch is not affected in homozygous klf2ash317 mutants.
Top panel figure shows vascular anatomy of a zebrafish embryo at 3dpf. White rectangle indicates the
location of aortic arches. DA denotes dorsal aorta. Bottom panel figures represent dorsal views on aortic
arches. White arrows indicate lateral dorsal aortae. White arrowheads indicate AA5x vessels. Scale
bar = 200μm. (B)Quantification of endothelial cell nuclei in 4 ISVs closest to the cloaca and corresponding
DLAV in WT and klf2ash317 mutants at 3dpf. Scale bar = 70μm.
doi:10.1371/journal.pone.0141611.g005
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microRNA 126 (miR-126) has been shown to be upregulated by klf2a and morpholino-
induced klf2a knockdown resulted in reduced miR-126 expression levels in zebrafish [18]. To
attempt to further explore the reason for the lack of phenotype in klf2ash317 mutants, we quan-
tified miR-126 levels in 72hpf klf2ash317 mutants compared with wildtypes. We found no
reduction in miR-126 levels in klf2ash317 mutants compared to wild types (Fig 11). This sug-
gests that although the mutation clearly induces a significant alteration in the klf2a transcript
in association with a truncated Klf2a protein, the downstream functions of klf2a appear not to
be perturbed.
Fig 6. Vascular development in vhlhu2117mutants is unaffected by the klf2ash317 mutation.Wildtype embryos exhibit angiogenesis typical for this
developmental stage– 3dpf (left figure, white arrow). Homozygous vhlhu2117 embryos show enlargement of vessels (ISVs and DLAV) with increased tortuosity
and looping of the DLAV (middle figure, right arrow). The same vascular phenotype was be observed in vhlhu2117 embryos in a homozygous klf2ash317
background (right figure, red arrow). Confocal images of Tg(fli1:eGFP) zebrafish embryos at 3dpf.. Scale bar = 70μm.
doi:10.1371/journal.pone.0141611.g006
Fig 7. Expression of HSCmarkers runx1 and cmyb is unaffected in homozygous klf2ash317 mutants at 36hpf. Expression patterns of HSCmarkers
runx1 (top panel) and cmyb (bottom panel) do not differ between the wildtype and klf2ash317 mutants at 36hpf. Black arrows indicate the aorta-gonad-
mesonephros (AGM) region and red arrows indicate caudal haematopoietic tissue (CHT). Numbers in the top left corners indicate number of embryos with
similar staining patterns out of total number of embryos examined. Scale bar = 500μm.
doi:10.1371/journal.pone.0141611.g007
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Discussion
In this study we describe for the first time the generation and characterisation of a stable
klf2amutant zebrafish. We find that, in contrast to several studies describing a range of
Fig 8. klf2b expression patterns do not differ between wildtype and klf2ash317 mutants. klf2bmRNA is detectable in the developing pectoral fin bud
(black arrows). Most of the embryos examined exhibit klf2bmRNA presence on the surface of the embryos representing epidermal cells as described before
[17, 48] (red arrowheads). A small proportion of both wildtype and klf2ash317 mutant embryos show vascular staining in the ISVs (red arrows) and/or in the
subintestinal veins (green arrows). There were no differences in staining patterns and especially in the level of vascular staining observed between wildtype
and klf2ash317 mutant embryos. Figures in bottom left corner of each image indicate the number of embryos with similar staining patterns out of total number
of embryos examined. Scale bar = 500μm.
doi:10.1371/journal.pone.0141611.g008
Fig 9. klf4a and biklf/klf4b/klf17 expression patterns do not differ between wildtype and klf2ash317 mutants at 48hpf. klf4a expression was detected in
epidermis (black arrows) and pectoral fins (red arrowheads) and biklf/klf4b/klf17 expression was detected in neuromasts of lateral line organ (red arrows) and
in hatching glands (black arrowheads) of wildtype embryos and klf2ash317 mutants in keeping with previously published data [17, 47] No vascular expression
of klf4a or biklf/klf4b/klf17 could be detected in any of the wildtype embryos or klf2ash317 mutants examined. Figures in bottom left corner of each image
indicate the number of embryos with similar staining patterns out of total number of embryos examined. Scale bar = 500μm.
doi:10.1371/journal.pone.0141611.g009
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cardiovascular phenotypes in klf2amorphant zebrafish, homozygous klf2ash317 mutant
embryos display no discernible cardiovascular abnormalities, survive into adulthood and are
fertile. There are several possible explanations for the discrepancy between the morphant and
klf2ash317 mutant phenotype, a phenomenon that is increasingly being recognised as targeted
mutants are generated for genes previously studied using morpholinos [25].
It is possible that some or all of the published klf2amorpholino studies are describing off-
target or toxic effects of the reagent used, rather than specific effects of klf2a knockdown. This
is perhaps particularly possible in the case of klf2a, expression of which is regulated by blood
Fig 10. klf2b knockdown does not alter heart rate or AA5x formation in klf2ash317 mutants. (A) klf2b
morpholino injection did not affect the heart rate of klf2ash317 mutants at either 48 or 72hpf. (B) AA5x vessel
formation (white arrowheads) is intact in klf2bmorphants in either a homozygous or heterozygous klf2ash317
mutant background. White arrows indicate lateral dorsal aortae. DA indicates dorsal aorta. Scale
bar = 200μm.
doi:10.1371/journal.pone.0141611.g010
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flow. Non-specific effects that reduce cardiac output would indirectly reduce klf2a expression
and confound interpretation of the phenotype. This could explain the findings that klf2amor-
pholino knockdown impairs AA5x [18] and HSC formation [19], both of which are impaired
in the absence of blood flow. It is harder to ascribe the phenotype of high-output heart failure
[15] to off-target effects or toxicity since this is a phenotype not commonly seen in morpholino
studies, although the pericardial oedema also reported in this study is commonly induced by
high-dose morpholino injections. However, high-output heart failure was not reported in the
later klf2amorpholino studies, suggesting that it was not observed by these groups.
Conversely, it is possible that the klf2ash317 mutation does not induce loss-of-function and
this accounts for the lack of a mutant phenotype. Despite concerns about the reliability of mor-
pholinos, and the increasing preference for using stable mutants, it remains challenging to con-
firm that a targeted mutation truly induces loss-of-function. The deletion in the genomic DNA
sequence of klf2ash317 mutants leads to a frame shift resulting in a premature stop codon that
Fig 11. Comparison of miR-126 expression levels in klf2ash317 mutants with wildtypes at 72hpf.
Expression levels of miR-126 do not differ between klf2ash317 and wildtypes at the observed time point.
Expression of miR-126 was normalized to U6 for relative quantification. Individual points represent relative
quantification of miR-126 in a pool of embryos relative to the mean expression in the wild-type group.
Summary data is displayed as mean ± SEM.
doi:10.1371/journal.pone.0141611.g011
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would remove the DNA binding motifs necessary for klf2a to function as a transcription factor.
Sequencing the cDNA from klf2ash317 mutants found no evidence that the deletion leads to an
alternatively spliced transcript that could remain functional. We were fortunate to obtain an
antibody with at least some degree of cross-reactivity against zebrafish Klf2a, since a lack of
suitable antibodies prevents assessment of the effect of targeted mutation on protein expression
in the case of most genes. Western blotting with this antibody confirmed loss of wildtype Klf2a
in klf2ash317 mutants. However, we did not detect a band of the predicted size of the mutant
transcript (13kDa) but instead detected a novel band of around 33kDa. Although it is possible
that this represents the predicted mutant protein with additional post-translational modifica-
tions, it is also possible that some mechanism has allowed the ribosome to produce a truncated
yet functional Klf2a protein in the face of the klf2ash317 mutation.
After initial submission of this paper, Rossi et al. published a description of a compensatory
mechanism that rescues the effect of egfl7mutants but not of egfl7morpholino knockdown, via
upregulation of Emilins [49]. Since the klf2ash317 mutation seems highly likely to perturb klf2a
function, yet does not affect miR-126 levels, we consider it most likely that a similar mecha-
nism exists for klf2a. We have shown that this compensation is not mediated by klf2b, but it is
entirely possible that other genes may rescue the effect of the the klf2ash317 mutation. Since for-
ward mutagenesis screens in zebrafish have been highly successful, not least for cardiovascular
phenotypes [50], such mechanisms appear not to compensate for many genes. However, the
existence of such mechanisms may explain the observation that in a large-scale zebrafish muta-
genesis study only 6% of disruptive mutations in protein-coding genes induced an observable
phenotype [27].
In summary, our work shows that even in the face of clear evidence of a potentially disrup-
tive mutation induced in a gene of interest, it is currently very difficult to be certain that this
leads to loss-of-function, and hence to be confident about the role of the gene in embryonic
development.
Supporting Information
S1 Checklist. NC3Rs ARRIVE Guidelines Checklist.
(PDF)
S1 Fig. klf2a vascular expression is blood flow-dependent. klf2a is expressed in zebrafish
embryonic vasculature of a WT embryo at 48hpf. Cessation of blood flow in the trunk vascula-
ture by an occlusion of proximal aorta in the gridlockmutants (indicated by a green arrow)
results in a complete loss of klf2a vascular expression distally to the occlusion. Blockage of
embryonic heart contractions by tnnt2MO results in significantly decreased klf2a vascular
expression. Pharmacological inhibition of heart contractions by tricaine from 32 to 48hpf
results in significantly decreased klf2a vascular expression. Interestingly tricaine also reduces
klf2a expression in the heart region and in the cells lateral to the most posterior notochord.
Red arrows indicate trunk vasculature, black arrows indicate the cells lateral to most posterior
notochord, white arrows indicate pectoral fins, black arrowheads indicate the cardiac outflow
tract and white arrowheads indicate cloaca. Numbers in top right corners indicate the number
of embryos with similar staining pattern out of all embryos examined. klf2a riboprobe used.
Scale bar = 500μm.
(TIF)
S2 Fig. klf2a wildtype and klf2ash317 coding sequences, primary protein structures and
klf2ash317 cDNA sequencing. (A) klf2a wildtype and klf2ash317 coding sequences. Exons are
colour coded in alternating black and blue colours. Nucleotides within the 19bp spacer between
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the klf2a TALEN L and R subunit binding sites are underlined. Targeted TALEN-induced
mutagenesis occurs around this region. Codons coding for amino acids that bind the zinc
atoms within the 3 tandem C2H2 zinc fingers at the C terminus of wildtype Klf2a protein are
highlighted in red. 14bp deletion in the klf2ash317 coding sequence causes disruption of the
reading frame. (B) Primary protein structures of Klf2a WT and Klf2a sh317 proteins are
aligned. Cysteine (C) and histidine (H) amino acids that bind zinc atoms within the 3 tandem
C2H2 zinc fingers at the C terminus of wildtype Klf2a protein are highlighted in red. (C)
Sequencing of reversely transcribed klf2ash317 mRNA confirmed the presence of expected
sequence in 23/23 sequencing reactions without any additional transcripts detected. Sequence
highlighted in blue (ACACCA) indicates the area of targeted mutagenesis in klf2a gene.
(TIF)
S3 Fig. klf2a expression patterns in klf2ash317 mutants.No differences in klf2aWISH staining
patterns were detected in klf2ash317 mutant embryos when compared to wildtype counterparts
at examined time points indicating the absence of nonsense-mediated mRNA decay (NMD) in
klf2ash317 mutants. Grey arrowheads indicate cloaca, black arrows indicate cells lateral to the
most posterior notochord, white arrows indicate pectoral fin, red arrows indicate trunk vascu-
lature, black arrowheads indicate the cardiac outflow tract, white arrowheads indicate neuro-
masts and green arrows indicate subintestinal veins. Numbers in the bottom left corners
indicate number of embryos with similar staining patterns out of total number of embryos
examined. Scale bar = 500μm.
(TIF)
S4 Fig. Formation of the AA5x vessel in blood flow dependent. (A) Vascular anatomy of a
zebrafish embryo at 3dpf. White rectangle indicates the location of aortic arches. DA denotes
dorsal aorta. Scale bar = 200μm. (B) Formation of AA5x vessels in unaffected in the WT
embryos (untreated controls) as indicated by the white arrowheads. White arrows point at lat-
eral dorsal aortae. AA5x vessel is missing in embryos treated with tricaine (middle panel) and
with BDM (right figure) which both prevent blood flow (green arrowheads). Formation of lat-
eral dorsal aortae is unaffected (white arrows). These findings confirm the previously published
data [18]. Scale bar = 70μm.
(TIF)
S5 Fig. Expression of HSC markers runx1 and cmyb is blood flow dependent. Expression
patterns of HSC markers runx1 (top panel) and cmyb (bottom panel) is significantly dimin-
ished in the tnnt2morphants which lack blood flow confirming previously published data [19].
Black arrows indicate the aorta-gonad-mesonephros (AGM) region and red arrows indicate
caudal haematopoietic tissue (CHT). Numbers in the top left corners indicate number of
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